Fortis Therapeutics
La Jolla
About Fortis Therapeutics
Fortis Therapeutics is immuno-oncology biotech focused on developing new antibody-drug conjugate therapies against CD46 for the treatment of late-stage multiple myeloma and late-stage prostate cancer and other indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $58.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2021)
- Website: fortistx.com
Industries & Categories
Biotechnology, Oncology, Therapeutics
Canonical: https://fsome.com/organization/fortis-therapeutics-128895 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.